Share
Raymond W. Cohen
CAIRDAC, SA, a pre-revenue medical technology company developing an autonomous leadless pacing system, has appointed Raymond W. Cohen as Chairman of its Board of Directors.
Cohen is an experienced medical technology executive and accredited public company director, bringing more than four decades of experience across the medtech industry. He co-founded Axonics, Inc., a company focused on implantable neuromodulation devices, and served as its Chief Executive Officer.
During his leadership at Axonics, Cohen guided the company through its commercial development and initial public offering in 2018. The company subsequently reported significant commercial growth, generating more than $1.2 billion in revenue during the four years following its commercial launch. Axonics was acquired by Boston Scientific in 2024 in a transaction valued at approximately $3.7 billion.
Cohen has also held leadership roles with other healthcare technology companies. In 2025, as Chairman of SoniVie Ltd., an Israeli clinical-stage company, he led the company through its $600 million sale. Later that year, he led the sale of Nalu Medical for $533 million.
He currently serves on the boards of several public and private healthcare companies, including Kestra Medical Technologies. Cohen is also an operating partner at Star51, a venture fund, and a venture partner with Andera Partners and Sherpa Capital Partners.
At CAIRDAC, Cohen will support the company as it advances development of its Autonomous Leadless Pacing System, a leadless, self-powered cardiac pacemaker designed to provide pacing without traditional implanted leads.
His extensive experience in medical technology, corporate leadership, commercialization and strategic transactions adds significant board-level expertise as CAIRDAC progresses toward future clinical and commercial milestones.
.webp "RWJBarnabas Health Appoints Jonathan P. Kyriacou as President and CEO of Jersey City Medical Center")
